These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 37249661)

  • 1. Implications of IL-21 in solid tumor therapy.
    Eivary SHA; Kheder RK; Najmaldin SK; Kheradmand N; Esmaeili SA; Hajavi J
    Med Oncol; 2023 May; 40(7):191. PubMed ID: 37249661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-cancer Therapies Employing IL-2 Cytokine Tumor Targeting: Contribution of Innate, Adaptive and Immunosuppressive Cells in the Anti-tumor Efficacy.
    Mortara L; Balza E; Bruno A; Poggi A; Orecchia P; Carnemolla B
    Front Immunol; 2018; 9():2905. PubMed ID: 30619269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The IL-2 cytokine family in cancer immunotherapy.
    Sim GC; Radvanyi L
    Cytokine Growth Factor Rev; 2014 Aug; 25(4):377-90. PubMed ID: 25200249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological effects of IL-21 on immune cells and its potential for cancer treatment.
    Ma M; Xie Y; Liu J; Wu L; Liu Y; Qin X
    Int Immunopharmacol; 2024 Jan; 126():111154. PubMed ID: 37977064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-21 triggers both cellular and humoral immune responses leading to therapeutic antitumor effects against head and neck squamous cell carcinoma.
    Nakano H; Kishida T; Asada H; Shin-Ya M; Shinomiya T; Imanishi J; Shimada T; Nakai S; Takeuchi M; Hisa Y; Mazda O
    J Gene Med; 2006 Jan; 8(1):90-9. PubMed ID: 16097036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular immunological approaches to biotherapy of human cancers--a review, hypothesis and implications.
    Becker Y
    Anticancer Res; 2006; 26(2A):1113-34. PubMed ID: 16619514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-12 promotes the proliferation and cytolytic maturation of immune effectors: implications for the immunotherapy of cancer.
    Zeh HJ; Hurd S; Storkus WJ; Lotze MT
    J Immunother Emphasis Tumor Immunol; 1993 Aug; 14(2):155-61. PubMed ID: 7904180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-21: a pleiotropic cytokine with potential applications in oncology.
    Croce M; Rigo V; Ferrini S
    J Immunol Res; 2015; 2015():696578. PubMed ID: 25961061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cetuximab therapy in head and neck cancer: immune modulation with interleukin-12 and other natural killer cell-activating cytokines.
    Luedke E; Jaime-Ramirez AC; Bhave N; Roda J; Choudhary MM; Kumar B; Teknos TN; Carson WE
    Surgery; 2012 Sep; 152(3):431-40. PubMed ID: 22770960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Which immunological parameters are clinically essential to monitor IL-2 cancer immunotherapy?
    Lissoni P; Brivio F; Viviani S; Fumagalli L
    J Biol Regul Homeost Agents; 1999; 13(2):110-4. PubMed ID: 10503734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].
    Herskind C; Fleckenstein K; Lohr J; Li CY; Wenz F; Lohr F
    Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
    Khawli LA; Hu P; Epstein AL
    Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 21 treatment in a murine model as a novel potential cytokine immunotherapy for colon cancer.
    Chen C; Liu X; Ren Y
    Adv Clin Exp Med; 2018 May; 27(5):583-589. PubMed ID: 29616746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy of cancer by IL-12-based cytokine combinations.
    Weiss JM; Subleski JJ; Wigginton JM; Wiltrout RH
    Expert Opin Biol Ther; 2007 Nov; 7(11):1705-21. PubMed ID: 17961093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of IL-21 in immune-regulation and tumor immunotherapy.
    di Carlo E; de Totero D; Piazza T; Fabbi M; Ferrini S
    Cancer Immunol Immunother; 2007 Sep; 56(9):1323-34. PubMed ID: 17447063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticancer Cytokines: Biology and Clinical Effects of Interferon-α2, Interleukin (IL)-2, IL-15, IL-21, and IL-12.
    Floros T; Tarhini AA
    Semin Oncol; 2015 Aug; 42(4):539-48. PubMed ID: 26320059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined Stimulation with Interleukin-18 and Interleukin-12 Potently Induces Interleukin-8 Production by Natural Killer Cells.
    Poznanski SM; Lee AJ; Nham T; Lusty E; Larché MJ; Lee DA; Ashkar AA
    J Innate Immun; 2017; 9(5):511-525. PubMed ID: 28633138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-27, a pleiotropic cytokine for fine-tuning the immune response in cancer.
    Beizavi Z; Zohouri M; Asadipour M; Ghaderi A
    Int Rev Immunol; 2021; 40(5):319-329. PubMed ID: 33146571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy.
    Sato T; Terai M; Tamura Y; Alexeev V; Mastrangelo MJ; Selvan SR
    Immunol Res; 2011 Dec; 51(2-3):170-82. PubMed ID: 22139852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
    O'Malley BW; Li D; McQuone SJ; Ralston R
    Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.